Once daily loratadine versus astemizole once daily

Annals of Allergy

Volumn 73, Issue 2, 1994, Pages 109-113

  Chervinsky, P ^a   Georgitis, J ^a   Banov, C ^a   Boggs, P ^a   Vande Stouwe, R ^a   Greenstein, S ^a  

^a Allergy and Asthma Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTEMIZOLE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DECONGESTIVE AGENT; LORATADINE;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CHILD; CLINICAL TRIAL; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; FATIGUE; HEADACHE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SOMNOLENCE; SYMPTOMATOLOGY; TOPICAL DRUG ADMINISTRATION; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ASTEMIZOLE; CHILD; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HAY FEVER; HUMAN; LORATADINE; MALE; MIDDLE AGE; SEASONS; SUPPORT, NON-U.S. GOV'T; WEIGHT GAIN;

EID: 0027956059     PISSN: 00034738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)